BIOLASE, Inc.

BIOL

$0.02

+27.39%

N/A+$0.00

Healthcare

Medical - Devices

NASDAQ

Inactive

BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced ...

Key Metrics of BIOL

Snapshot

Latest / TTM · 4 periods

Market Cap

$731,942.00

ROCE

-116.2%

EV / EBITDA

-0.78x

+0.0% YoY

FCF Yield

-2104.3%

-1028.2% YoY

Cash Conversion Cycle

101.1d

Current Ratio

1.26

Quick take

TTM —

Positive CCC

Key Metrics

Latest / TTM · 4 periods

Valuation trend

Valuation trend table

Metric	2021	2022	2023	TTM
Market CapTotal market value of all shares outstanding.	$57.62M	$4.50M	$1.43M	$731,942
Enterprise ValueCompany value including debt and cash adjustments.	$42.70M	$16.01M	$12.78M	$12.08M
EV / SalesHow many dollars investors pay per dollar of sales.	1.09x	0.33x	0.26x	0.25x
EV / EBITDAValuation multiple versus operating earnings before non-cash charges.	-3.17x	-0.63x	-0.83x	-0.78x
Net Debt / EBITDALeverage ratio using net debt divided by EBITDA.	1.11	-0.46	-0.73	-0.73

Returns + ROCE gauge

ROCE latest

-116.2%

Prev year -116.2%

Returns + ROCE gauge table

Metric	2021	2022	2023	TTM
ROEProfit generated from shareholders' equity.	-64.1%	-585.7%	8353.0%	-888.9%
ROAProfit generated from total assets.	-29.2%	-75.0%	-58.8%	-58.8%
ROICReturn generated on invested operating capital.	-33.8%	-128.6%	-120.4%	-89.8%
ROCEOperating return on long-term capital used.	-38.9%	-124.3%	-116.2%	-116.2%
Earnings YieldEarnings as a percentage of market value.	-28.0%	-635.7%	-1441.4%	-80719.9%

Cash flow quality

Cash flow quality table

Metric	2021	2022	2023	TTM
FCFFCash flow available to all capital providers.	$-15.18M	$-27.73M	$-13.04M	$-13.04M
FCFECash flow available to equity holders after debt flows.	$-17.42M	$-31.49M	$-15.57M	$-15.57M
FCF YieldFree cash flow divided by market capitalization.	-30.2%	-676.8%	-1076.0%	-2104.3%
Income QualityHow well accounting earnings are backed by cash flow.	1.03	0.93	0.68	0.68
Capex / OCFShare of operating cash flow spent on capital expenditures.	-4.2%	-13.9%	-9.3%	-9.3%

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	TTM
DSOAverage days to collect cash from customers.	39.5d	44.0d	40.7d	40.7d
DIOAverage days inventory stays before being sold.	208.3d	178.1d	128.6d	128.6d
DPOAverage days the company takes to pay suppliers.	53.3d	64.9d	68.2d	68.2d
Operating CycleTime from buying inventory to collecting receivables.	247.7d	222.1d	169.3d	169.3d
Cash Conversion CycleNet days cash is tied in operations.	194.4d	157.2d	101.1d	101.1d

Snapshot

Latest / TTM: —

Market Cap

$731,942

ROE

-888.9%

FCF Yield

-2104.3%

Current Ratio

1.26

Upstream

IPG Photonics Corporation (IPG Medical)NASDAQ:IPGPSingle-source Power Supply VendorSingle-source Laser Crystal VendorSingle-source Fiber Components VendorDinsmore Inc. (an ADDMAN Group company)Carbon, Inc.Coherent Corp.NYSE:COHR

Downstream

Henry Schein, Inc.NASDAQ:HSICFrontier DentalSinclair Dental (Medline Sinclair)Streamhealth GroupIBC GmbHMegaGen Implant Co., Ltd.Dental Care Alliance (DCA)Valam CorporationBIOLASE Europe GmbH

Proxies

IPG Photonics CorporationNASDAQ:IPGP Henry Schein, Inc.NASDAQ:HSIC Coherent Corp.NYSE:COHR

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

BIOLASE, Inc.

Key Metrics of BIOL

Key Metrics

Valuation trend

Returns + ROCE gauge

Cash flow quality

Operating efficiency

Snapshot

Supply Chain of BIOL

Upstream

Downstream

Proxies

Key Metrics of BIOL

Key Metrics

Valuation trend

Returns + ROCE gauge

Cash flow quality

Operating efficiency

Snapshot

Supply Chain of BIOL

Upstream

Downstream

Proxies